Literature DB >> 20486908

Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction.

S Dettwiler1, T McKee, K Hadaya, F Chappuis, C van Delden, S Moll.   

Abstract

Visceral leishmaniasis (VL) due to Leishmania infantum is an endemic parasitic infection in the Mediterranean area. It most commonly affects immunosuppressed individuals, especially HIV patients and less frequently organ transplant recipients. Renal involvement seems to be frequent and is mostly associated with tubulointerstitial nephritis, as described in autopsy reports. In the 61 cases of renal transplant recipients with VL reported in the literature, renal dysfunction was noted at clinical presentation and was more frequently observed as a complication of antiparasitic therapy. However, no pathological analysis of the allograft lesions was reported. We present the case of a Swiss renal transplant recipient who developed VL after vacations in Spain and Tunisia, complicated by acute parasitic nephritis in the renal allograft 3 months after a well-conducted treatment of liposomal amphotericin B.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486908     DOI: 10.1111/j.1600-6143.2010.03125.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 2.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

Review 3.  Renal involvement in leishmaniasis: a review of the literature.

Authors:  Anna Clementi; Giorgio Battaglia; Matteo Floris; Pietro Castellino; Claudio Ronco; Dinna N Cruz
Journal:  NDT Plus       Date:  2011-03-21

4.  Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Authors:  Matteo Vassallo; Olivier Moranne; Damien Ambrosetti; Pierre-Yves Jeandel; Christelle Pomares; Elisabeth Cassuto; Annick Boscagli; Guillaume Giraud; Nathalie Montagne; Chiara Dentone; Ilaria Demacina; Barbara Villaggio; Giovanni Secondo; Giuseppe Ferrea; Corinne Passeron; Laurence Saudes; Regis Kaphan; Pierre Marty; Eric Rosenthal
Journal:  BMC Infect Dis       Date:  2014-10-30       Impact factor: 3.090

5.  Epidemiologic, clinical, diagnostic and therapeutic aspects of visceral leishmaniasis in renal transplant recipients: experience from thirty cases.

Authors:  Avelar Alves de Silva; Álvaro Pacheco e Silva Filho; Ricardio de Castro Cinta Sesso; Ronaldo de Matos Esmeraldo; Cláudia Maria Costa de Oliveira; Paula Frassinetti Fernandes; Rodrigo Alves de Oliveira; Leila Silveira Veira de Silva; Valencio Pereira de Carvalho; Carlos Henrique Nery Costa; Jesusmar Ximenes Andrade; Diana Marisa Barros da Silva; Roosevelt Valente Chaves
Journal:  BMC Infect Dis       Date:  2015-02-25       Impact factor: 3.090

6.  Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Anila Siddiqui; Patrick S Quint; Bobbi S Pritt
Journal:  Kidney Int Rep       Date:  2016-06-23

Review 7.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

Review 8.  New insights into leishmaniasis in the immunosuppressed.

Authors:  Hannah Akuffo; Carlos Costa; Johan van Griensven; Sakib Burza; Javier Moreno; Mercè Herrero
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10

Review 9.  Kidney involvement in leishmaniasis--a review.

Authors:  Geraldo Bezerra da Silva Junior; Elvino José Guardão Barros; Elizabeth De Francesco Daher
Journal:  Braz J Infect Dis       Date:  2014-03-29       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.